Effect of preoperative intravenous oxycodone on low-dose ropivacaine spinal anaesthesia combined with intrathecal fentanil

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006998

Enrollment

Unknown

Registered

2015-08-29

Start date

2015-09-07

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Group O:Group O will be given preoperative intravenous oxycodone 0.1mg/kg

Group C:Group C will be given 0.1ml/kg normal saline.

Eligibility

Sex/Gender

Male

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with American Society of Anesthesiologists (ASA) I to II undergoing elective TURP were admitted to this study.

Exclusion criteria

Exclusion criteria: Patients having histories of substance abuse, mental disturbance and neurological disease, and allergic reactions to opioids were excluded from the clinical trial.

Design outcomes

Primary

Measure	Time frame
The time to the first analgesic request;	—

Countries

China

Contacts

Public ContactWang Na

lilyly12345@163.com+86 13578899126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026